Olema Pharmaceuticals, Inc.
NASDAQ: OLMA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sean Bohen
- Employees
- 96
- Headquarters
- San Francisco, United States
- IPO year
- 2020
- Market cap
- $973.1M
- Website
- https://www.olema.com
Loading OLMA…
Loading profile data…Frequently asked questions about OLMA
What does Olema Pharmaceuticals, Inc. (OLMA) do?
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promisin...
Where does OLMA trade?
Olema Pharmaceuticals, Inc. (OLMA) trades on the NASDAQ Global Select.
What sector is OLMA in?
Olema Pharmaceuticals, Inc. (OLMA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Olema Pharmaceuticals, Inc.?
Sean Bohen is the chief executive officer of Olema Pharmaceuticals, Inc. (OLMA).
Where is Olema Pharmaceuticals, Inc. headquartered?
Olema Pharmaceuticals, Inc. is headquartered in United States.
Does OLMA pay a dividend?
Olema Pharmaceuticals, Inc. (OLMA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OLMA go public?
Olema Pharmaceuticals, Inc. (OLMA) completed its initial public offering in 2020.